Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Janssen Pharmaceuticals Inc. Stories

2014-04-08 23:32:37

No-cost consultations from a national network of attorneys are now available to consumers of all ages who may be seeking compensation over allegations of gynecomastia, other side effects. San Diego, CA (PRWEB) April 08, 2014 http://www.resource4thepeople.com/defectivedrugs/risperdal.html Resource4thePeople announced today that its national network of attorneys has expanded its free legal consultations over allegations that the antipsychotic medication Risperdal may cause a breast-growth...

2014-03-20 23:29:36

National network of attorneys initiates offer of no-cost consultations to consumers seeking compensation for allegations of gynecomastia, other side effects. San Diego, CA (PRWEB) March 20, 2014 http://www.resource4thepeople.com/defectivedrugs/risperdal.html Resource4thePeople announced today that its national network of attorneys is now investigating claims over allegations that the antipsychotic medication Risperdal may cause a breast-growth condition known as gynecomastia or other side...

2014-03-10 08:29:31

Court Finds Janssen Pharmaceuticals' Drug Topamax Caused Child's Cleft Palate ALTON, Ill., March 10, 2014 /PRNewswire/ -- A jury last week awarded a $3 million verdict to the family of a 5-year-old child born with bilateral cleft palate and lip as a result of the mother taking Topamax during pregnancy. Simmons Browder Gianaris Angelides & Barnerd LLC, a national complex litigation firm, represented parents Kelly and Brian Anderson against drug manufacturer Janssen...

2014-02-18 23:25:00

Collaboration will create methodologies to drive improved decision-making in exploratory phase development. Reston, Virginia (PRWEB) February 18, 2014 Aptiv Solutions, a global biopharmaceutical and medical device development services company leading the adoption of innovative clinical trial approaches such as adaptive design, today announced that Novartis Pharma AG, Janssen Pharmaceuticals Inc, and Eli Lilly have joined them in co-founding the ADDPLAN DF Consortium. The members of the...

2014-01-16 16:24:28

RARITAN, N.J., Jan. 16, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee has voted against the approval of the use of XARELTO(®) (rivaroxaban), an oral anticoagulant, to reduce the risk of thrombotic cardiovascular events in patients with Acute Coronary Syndrome (ACS) in combination with standard antiplatelet therapy. Janssen is seeking approval of...

2013-12-31 23:21:39

The Firm is actively investigating Risperdal lawsuit claims on behalf of individuals who may have developed male breast growth, a condition referred to as gynecomastia, and other complications after taking the medication. New York, NY (PRWEB) December 31, 2013 Bernstein Liebhard LLP has published a new Risperdal lawsuit (http://www.risperdalbreastslawsuit.com/) website for anyone who may have experienced male gynecomastia and other side effects allegedly caused by the anti-psychotic...

2013-12-20 23:24:44

http://www.DrugNews.net is the web’s premier source for prescription drug warnings, research, side effects and legal news. Visit the DrugNews Center today. New York, NY (PRWEB) December 20, 2013 The medication safety advocates at DrugNews.net are announcing updated information for patients and parents of those who have taken the antipsychotic drug Risperdal. Patients alleging the drug caused abnormal breast growth have asked a judge to unseal data from Risperdal clinical studies,...

2013-11-08 23:03:50

The firm is currently offering Risperdal lawsuit evaluations to those who allege that they suffered from the drug’s alleged side effects. (PRWEB) November 08, 2013 Drug maker Johnson & Johnson has agreed to pay $2.2 billion in civil and criminal fines to settle claims it improperly marketed the antipsychotic medication Risperdal to children, seniors and people with developmental disabilities. The Rottenstein Law Group LLP, which represents clients in Risperdal lawsuits, notes that...

2013-11-05 16:27:39

FORT LAUDERDALE, Fla., Nov. 5, 2013 /PRNewswire/ -- South Florida consumer advocate and leading false claims attorney Gary M. Farmer, Jr., a partner with Farmer, Jaffe, Weissing, Edwards, Fistos & Lehrman, P.L., has successfully litigated his third major false claims case against a global pharmaceutical company. Today, the United States Department of Justice announced a settlement against pharmaceutical giant Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals Inc. Johnson...

2013-11-04 12:28:23

NEW BRUNSWICK, N.J., Nov. 4, 2013 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) and its subsidiaries, Janssen Pharmaceuticals, Inc. and Scios Inc., today announced they have finalized previously disclosed settlement agreements with the U.S. Department of Justice (DOJ) and 45 states resolving federal investigations and state Medicaid claims related to past promotional practices of RISPERDAL(®) from 1999 through 2005, and other matters. The resolution includes total settlement...